Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,371,575
-
Total 13F shares
-
16,678,999
-
Share change
-
-4,676,454
-
Total reported value
-
$59,949,585
-
Put/Call ratio
-
158%
-
Price per share
-
$3.70
-
Number of holders
-
44
-
Value change
-
-$4,783,345
-
Number of buys
-
19
-
Number of sells
-
25
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q4 2022
As of 31 Dec 2022,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,678,999 shares.
The largest 10 holders included
Privium Fund Management B.V., ADAGE CAPITAL PARTNERS GP, L.L.C., M28 Capital Management LP, Opaleye Management Inc., MACQUARIE GROUP LTD, Ikarian Capital, LLC, MARSHALL WACE, LLP, DEUTSCHE BANK AG\, MORGAN STANLEY, and TWO SIGMA INVESTMENTS, LP.
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.